Pharmacology

Action Mechanism of Action Reference
INHIBITOR C5a anaphylatoxin chemotactic receptor inhibitor Other Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 2 D009369 ClinicalTrials
Severe Acute Respiratory Syndrome 2 D045169 ClinicalTrials
Pemphigoid, Bullous 2 D010391 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4594463
FDA SRS DW4CE8MKS9